<VariationArchive VariationID="858405" VariationName="NM_000292.3(PHKA2):c.3371_3377dup (p.Val1127fs)" VariationType="Duplication" Accession="VCV000858405" Version="7" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-28" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="849878" VariationID="858405">
      <GeneList>
        <Gene Symbol="PHKA2" FullName="phosphorylase kinase regulatory subunit alpha 2" GeneID="5256" HGNC_ID="HGNC:8926" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xp22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18892298" stop="18984114" display_start="18892298" display_stop="18984114" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18910415" stop="19002479" display_start="18910415" display_stop="19002479" Strand="-" />
          </Location>
          <OMIM>300798</OMIM>
        </Gene>
        <Gene Symbol="PHKA2-AS1" FullName="PHKA2 antisense RNA 1" GeneID="100132163" HGNC_ID="HGNC:44110" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>Xp22.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18890296" stop="18894975" display_start="18890296" display_stop="18894975" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000292.3(PHKA2):c.3371_3377dup (p.Val1127fs)</Name>
      <CanonicalSPDI>NC_000023.11:18894363:GATTCGA:GATTCGAGATTCGA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp22.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="18894363" stop="18894364" display_start="18894363" display_stop="18894364" variantLength="7" positionVCF="18894363" referenceAlleleVCF="C" alternateAlleleVCF="CGATTCGA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="18912481" stop="18912482" display_start="18912481" display_stop="18912482" variantLength="7" positionVCF="18912481" referenceAlleleVCF="C" alternateAlleleVCF="CGATTCGA" />
      </Location>
      <ProteinChange>V1127fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.18912482_18912488dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.18912482_18912488dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.18894364_18894370dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.18894364_18894370dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016622.1" sequenceAccession="NG_016622" sequenceVersion="1" change="g.94993_94999dup">
            <Expression>NG_016622.1:g.94993_94999dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_029379.1" sequenceAccession="NR_029379" sequenceVersion="1" change="n.685_691dup">
            <Expression>NR_029379.1:n.685_691dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000292.3" sequenceAccession="NM_000292" sequenceVersion="3" change="c.3371_3377dup" MANESelect="true">
            <Expression>NM_000292.3:c.3371_3377dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000283.1" sequenceAccession="NP_000283" sequenceVersion="1" change="p.Val1127fs">
            <Expression>NP_000283.1:p.Val1127fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2047492720" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000292.3(PHKA2):c.3371_3377dup (p.Val1127fs) AND Glycogen storage disease IXa1" Accession="RCV001064276" Version="7">
        <ClassifiedConditionList TraitSetID="7454">
          <ClassifiedCondition DB="MedGen" ID="C3694531">Glycogen storage disease IXa1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21646031</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24055370</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25266922</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28468868</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7847371</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9870210</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="7454" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2237" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Glycogenosis type 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hepatic phosphorylase kinase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphorylase kinase deficiency of liver</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GSD VIII</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glycogen storage disease 8</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">LIVER GLYCOGENOSIS, X-LINKED, TYPE I</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Glycogen storage disease IXa1</ElementValue>
                <XRef ID="MONDO:0010598" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GSD8</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">GSD9A1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG1</ElementValue>
                <XRef Type="MIM" ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">XLG2</ElementValue>
                <XRef ID="306000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PYKL</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Phosphorylase kinase (PhK) deficiency causing glycogen storage disease type IX (GSD IX) results from deficiency of the enzyme phosphorylase b kinase, which has a major regulatory role in the breakdown of glycogen. The two types of PhK deficiency are liver PhK deficiency (characterized by early childhood onset of hepatomegaly and growth restriction, and often, but not always, fasting ketosis and hypoglycemia) and muscle PhK deficiency, which is considerably rarer (characterized by any of the following: exercise intolerance, myalgia, muscle cramps, myoglobinuria, and progressive muscle weakness). While symptoms and biochemical abnormalities of liver PhK deficiency were thought to improve with age, it is becoming evident that affected individuals need to be monitored for long-term complications such as liver fibrosis and cirrhosis.</Attribute>
                <XRef ID="NBK55061" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18386" />
                <XRef ID="18386" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21634085</ID>
                <ID Source="BookShelf">NBK55061</ID>
              </Citation>
              <XRef ID="264580" DB="Orphanet" />
              <XRef ID="C3694531" DB="MedGen" />
              <XRef ID="MONDO:0010598" DB="MONDO" />
              <XRef Type="MIM" ID="306000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2394728" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6129011|MedGen:C0017927" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001229166" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">7847371</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9870210</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21646031</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21911307</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24055370</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25266922</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28468868</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the PHKA2 protein in which other variant(s) (p.Pro1205Leu) have been determined to be pathogenic (PMID: 7847371, 9870210, 21646031, 21911307, 24055370, 25266922, 28468868). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 858405). This variant has not been reported in the literature in individuals affected with PHKA2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Val1127Argfs*78) in the PHKA2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 109 amino acid(s) of the PHKA2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PHKA2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.18912481_18912482insGATTCGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0017927" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2394728" TraitType="Disease" MappingType="XRef" MappingValue="C0017927" MappingRef="MedGen">
        <MedGen CUI="C3694531" Name="Glycogen storage disease IXa1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

